Beacon Capital Management LLC (Tennessee)’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10
| Closed | -$1 | – | 1161 |
|
|
2023
Q4 | $1 | Hold |
10
| – | – | ﹤0.01% | 985 |
|
|
2023
Q3 | $1 | Hold |
10
| – | – | ﹤0.01% | 1025 |
|
|
2023
Q2 | $1 | Hold |
10
| – | – | ﹤0.01% | 1025 |
|
|
2023
Q1 | $3 | Hold |
10
| – | – | ﹤0.01% | 945 |
|
|
2022
Q4 | $2 | Hold |
10
| – | – | ﹤0.01% | 994 |
|
|
2022
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 1011 |
|
|
2022
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 969 |
|
|
2022
Q1 | $0 | Buy |
+10
| New | – | ﹤0.01% | 969 |
|